SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men
6 references·16 citing·32 second hop
Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men (2013)Effects of Suvorexant, an Orexin Receptor…Orexin receptor antagonism for treatment of insomnia (2012)Orexin receptor antagonism fo…Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia (2010)Discovery of the Dual Orexin …Subjective and Objective Sleepiness in the Active Individual (1990)Subjective and Objective Slee…The leeds sleep evaluation questionnaire in psychopharmacological investigations?a review (1980)The leeds sleep evaluation qu…The use of analogue scales in rating subjective feelings (1974)The use of analogue scales in…A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)A manual for standardized ter…The orexin story and orexin receptor antagonists for the treatment of insomnia (2023)The orexin story and orexin r…Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations (2023)Targeting Orexin Receptors fo…Relationship Between Nutritional Status and Insomnia Severity in Older Adults (2019)Relationship Between Nutritio…Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications (2018)Orexin receptor antagonists f…Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials (2016)Suvorexant in Patients with I…Pharmacological Treatment of Insomnia (2016)Pharmacological Treatment of …On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly (2016)On-the-road driving performan…Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant (2016)Novel class of medications, o…Suvorexant: The first orexin receptor antagonist to treat insomnia (2015)Suvorexant: The first orexin …Suvorexant (2015)SuvorexantOn-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers (2015)On-the-Road Driving Performan…Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data (2015)Effects of suvorexant on slee…Suvorexant: First Global Approval (2014)Suvorexant: First Global Appr…Suvorexant, a dual orexin receptor antagonist for the management of insomnia. (2014)Suvorexant, a dual orexin rec…Suvorexant for the treatment of insomnia (2014)Suvorexant for the treatment …Optimizing the Pharmacologic Treatment of Insomnia (2013)Optimizing the Pharmacologic …Insomnia and its relationship to health-care utilization, work absenteeism, productivity and accidents (2008)Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? (2014)Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials (2014)Validation of the Insomnia Severity Index as an outcome measure for insomnia research (2001)The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications (2007)Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR ) (2010)The assessment and management of insomnia: an update (2019)Diagnostic and Statistical Manual of Mental Disorders. (2000)Diagnostic and Statistical Manual of Mental Disorders (2013)Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies (2021)A Growing Edge of Measurement of Feelings [ Abridged ] (1969)Sensitivity and accuracy of the visual analogue scale: a psycho‐ physical classroom experiment. (1978)Instrumentation to describe subjective sleep characteristics in healthy subjects (1987)Efficacy of Agomelatine in Generalized Anxiety Disorder (2008)The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial (2010)L’examen Clinique en Psychologie (1959)The hyperarousal model of insomnia: A review of the concept and its evidence (2009)Mortality Risk of Hypnotics: Strengths and Limits of Evidence (2015)Zolpidem and Gender: Are Women Really At Risk? (2019)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Diagnostic and Statistical Manual of Mental Disorders (2013)International Classification of Sleep Disorders-Third Edition (2014)Diagnostic and Statistical Manual of Mental Disorders (2022)Insomnia in neurological disorders: Prevalence, mechanisms, impact and treatment approaches (2023)Clinical applications of visual analogue scales: a critical review (1988)Oxytocin Attenuates Amygdala Reactivity to Fear in Generalized Social Anxiety Disorder (2010)The Cumulative Cost of Additional Wakefulness: Dose-Response Effects on Neurobehavioral Functions and Sleep Physiology From Chronic Sleep Restriction and Total Sleep Deprivation (2003)Systematic Interindividual Differences in Neurobehavioral Impairment from Sleep Loss: Evidence of Trait-Like Differential Vulnerability (2004)Validation of the Karolinska sleepiness scale against performance and EEG variables (2006)The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research (1989)Impact of sleep debt on metabolic and endocrine function (1999)Meta-Analysis of Quantitative Sleep Parameters From Childhood to Old Age in Healthy Individuals: Developing Normative Sleep Values Across the Human Lifespan (2004)
this work references cited by second hop

References

  • 1968A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects11,772 cited
  • 1990Subjective and Objective Sleepiness in the Active Individual3,088 cited
  • 1974The use of analogue scales in rating subjective feelings1,977 cited
  • 2010Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia379 cited
  • 2012Orexin receptor antagonism for treatment of insomnia322 cited
  • 1980The leeds sleep evaluation questionnaire in psychopharmacological investigations?a review319 cited

Cited by

  • 2023The orexin story and orexin receptor antagonists for the treatment of insomnia119 cited
  • 2016Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials87 cited
  • 2015Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data79 cited
  • 2015On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy Volunteers76 cited
  • 2015Suvorexant72 cited
  • 2015Suvorexant: The first orexin receptor antagonist to treat insomnia70 cited
  • 2016Pharmacological Treatment of Insomnia68 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2023Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations64 cited
  • 2014Suvorexant: First Global Approval64 cited
  • 2019Relationship Between Nutritional Status and Insomnia Severity in Older Adults59 cited
  • 2014Suvorexant for the treatment of insomnia59 cited
  • 2014Suvorexant, a dual orexin receptor antagonist for the management of insomnia.53 cited
  • 2018Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications53 cited
  • 2016On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderly52 cited
  • 2016Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant49 cited
  • 2013Optimizing the Pharmacologic Treatment of Insomnia49 cited